2,354 research outputs found

    Northern Ireland statistics from October 2014 to March 2015

    Get PDF

    Steps to Work Statistical Factsheet : Northern Ireland Statistics from September 2008 to June 2014

    Get PDF

    Statistics and Registration Service Act 2007 (Disclosure of Pupil Information) Regulations (Northern Ireland) 2013

    Get PDF

    Statistics and Registration Service Act 2007 (Disclosure of Higher Education Student Information) Regulations (Northern Ireland) 2013

    Get PDF

    Palliative and End of Life Care for Black, Asian, and Minority Ethnic Groups in the UK

    Get PDF
    This report marks the start of a programme of work by many partners. A better understanding of the nation's changing demographics, of the needs of individual ethnic and cultural groups and of the types of services which will best meet their end of life care needs must be early outputs from the partnership. There are many areas which researchers will investigate further and many opportunities for service providers to work together with local communities to develop care which is sensitive and responsive to their needs as well as on a scale which will be needed for the large numbers of people who could benefi

    Drug use in Ireland and Northern Ireland: 2006/2007 drug prevalence survey: cocaine results: bulletin 4.

    Get PDF
    This bulletin provides a comprehensive overview of many different aspects of cocaine use in Ireland and Northern Ireland. It presents data gathered in the All Ireland Drug Prevalence Survey 2006/2007 relating to both cocaine powder and crack cocaine use on a lifetime (ever used), last year (recent use), and last month (current use) basis. The bulletin also examines age of first use, regular use, and method of taking cocaine, ease of obtaining cocaine, reasons for stopping use, perceptions of risk and the profile of cocaine users. The survey was carried out by Ipsos MORI in Ireland and by the Central Survey Unit of the Northern Ireland Statistics and Research Agency in Northern Ireland according to standards set by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

    Drug use in Ireland & Northern Ireland 2006/2007: drug prevalence survey bulletin 2: Regional Drugs Task Force (Ireland) & Health and Social Services Board (Northern Ireland) results.

    Get PDF
    This bulletin presents key findings at a local level from the second drug prevalence survey of households in both Ireland and Northern Ireland. The survey sampled a representative number of people aged between 15 and 64 during late 2006 and early 2007. The survey was carried out by Ipsos MORI in Ireland and by the Central Survey Unit of the Northern Ireland Statistics and Research Agency in Northern Ireland according to standards set by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).This bulletin presents results relating to drug prevalence on a lifetime, last year (recent) and last month (current) basis for illegal and other drugs including alcohol and tobacco for each Regional Drug Task Force Area (former Health Board areas) in Ireland, and Health and Social Service Board (HSSB) in Northern Ireland

    Estimating the incidence, prevalence and true cost of asthma in the UK: secondary analysis of national stand-alone and linked databases in England, Northern Ireland, Scotland and Wales-a study protocol.

    Get PDF
    INTRODUCTION: Asthma is now one of the most common long-term conditions in the UK. It is therefore important to develop a comprehensive appreciation of the healthcare and societal costs in order to inform decisions on care provision and planning. We plan to build on our earlier estimates of national prevalence and costs from asthma by filling the data gaps previously identified in relation to healthcare and broadening the field of enquiry to include societal costs. This work will provide the first UK-wide estimates of the costs of asthma. In the context of asthma for the UK and its member countries (ie, England, Northern Ireland, Scotland and Wales), we seek to: (1) produce a detailed overview of estimates of incidence, prevalence and healthcare utilisation; (2) estimate health and societal costs; (3) identify any remaining information gaps and explore the feasibility of filling these and (4) provide insights into future research that has the potential to inform changes in policy leading to the provision of more cost-effective care. METHODS AND ANALYSIS: Secondary analyses of data from national health surveys, primary care, prescribing, emergency care, hospital, mortality and administrative data sources will be undertaken to estimate prevalence, healthcare utilisation and outcomes from asthma. Data linkages and economic modelling will be undertaken in an attempt to populate data gaps and estimate costs. Separate prevalence and cost estimates will be calculated for each of the UK-member countries and these will then be aggregated to generate UK-wide estimates. ETHICS AND DISSEMINATION: Approvals have been obtained from the NHS Scotland Information Services Division's Privacy Advisory Committee, the Secure Anonymised Information Linkage Collaboration Review System, the NHS South-East Scotland Research Ethics Service and The University of Edinburgh's Centre for Population Health Sciences Research Ethics Committee. We will produce a report for Asthma-UK, submit papers to peer-reviewed journals and construct an interactive map
    corecore